Standout Papers

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study 2010 2026 2015 2020 488
  1. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study (2010)
    David M. Thomas, Robert M. Henshaw et al. The Lancet Oncology
  2. Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a) (2022)
    Michael J. Koren, Patrick M. Moriarty et al. Nature Medicine

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 65 standout
Sub-graph 1 of 18

Citing Papers

Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2025 Standout
Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
6 intermediate papers

Works of Winnie Sohn being referenced

Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis
2017
Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus
2015
and 2 more

Author Peers

Author Last Decade Papers Cites
Winnie Sohn 669 580 268 487 26 1.5k
A. H. M. Taminiau 356 879 134 1255 29 1.8k
A. H. M. Taminiau 237 798 138 1016 26 1.4k
Béatrice Marie 362 303 36 429 47 1.3k
D. C. Mangham 342 763 24 818 35 1.4k
Brenda Caparros 669 809 99 1775 18 2.2k
Howard Yeh 1186 127 310 275 24 1.7k
María Eugenia Ibarrarán Viniegra 1423 139 414 296 17 1.6k
Ronald G. Swee 188 1571 24 990 25 2.0k
Angela Cioffi 941 373 57 1497 55 2.1k
Sandrine Théoleyre 755 155 40 205 25 1.4k

All Works

Loading papers...

Rankless by CCL
2026